Alzheimer's Disease Trial, Recruiting NCT05977088 Sponsor: Istanbul Medipol University Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05977088
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Alzheimer's Disease using a recognised set of medical diagnostic guidelines known as the NINCDS-ADRDA criteria
  • People who are older than 55 years of age
  • People whose dementia severity falls within a specific range (a score of 1 to 2) on a standard assessment scale called the Clinical Dementia Rating Scale, which covers mild to moderate dementia
  • People who do not have any other condition that affects memory or thinking
  • People who are willing to participate in the study voluntarily

Who may not be able to join:

  • People whose own consent, or the consent of a relative, is not provided
  • People who are unable to take part in the full study process — for example, because they live in a different city
  • People who have a history of head injury combined with alcohol or substance misuse
  • People who have had a severe stroke or have other significant neurological conditions affecting the nervous system
  • People who have a metal implant in the head, a pacemaker, or any other reason that a brain stimulation technique called TMS would not be safe for them
  • People who are currently taking, have recently taken (within the past month), or are enrolled in a study involving an experimental drug targeting Alzheimer's disease, or a brain stimulation treatment such as TCS or TMS — other than standard approved Alzheimer's medications — that could affect the study results (confirm with trial site for full details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lutfu Hanoglu, Prof. DR. MD, Medipol University

Phone: +90 444 8 544

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medipol University Hospital
Registry
ClinicalTrials.gov
Start date
16 February 2022
Est. completion
15 May 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

The Mini Mental State Examination; Neuropsychiatric Inventory; Alzheimer's Disease Assessment Scale; ADSL; Geriatric Depression Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov